Biological characteristics of γδT cells and application in tumor immunotherapy

被引：6
|
作者：
Zhu, Renhong [1 ,2 ]
Yan, Qian [3 ]
Wang, Yashu [4 ]
Wang, Keqiang [1 ]
机构：
[1] Shandong First Med Univ, Dept Lab Med, Affiliated Hosp 2, Tai An, Peoples R China
[2] Taian Tumor Prevent & Treatment Hosp, Dept Lab Med, Tai An, Peoples R China
[3] Second Hosp Tradit Chinese Med, Dept Lab Med, Tai An, Peoples R China
[4] Qingdao Univ, Dept Lab Med, Affiliated Taian City Cent Hosp, Tai An, Peoples R China
来源：
FRONTIERS IN GENETICS | 2023年 / 13卷
基金：
中国国家自然科学基金;
关键词：
gamma delta T cells; tumor; immunotherapy; progress; biological; BISPHOSPHONATE ZOLEDRONIC ACID; HUMAN NATURAL-KILLER; STEM-LIKE CELLS; ALPHA-BETA; PERIPHERAL-BLOOD; ADOPTIVE IMMUNOTHERAPY; HEPATOCELLULAR-CARCINOMA; CELLULAR IMMUNOTHERAPY; CHEMOTHERAPY IMPROVES; DENDRITIC CELLS;
D O I：
10.3389/fgene.2022.1077419
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Human gamma delta T cells are a special immune cell type which exist in small quantities in the body, do not require processing and presentation for antigen recognition, and have non-major histocompatibility complex (MHC)-restricted immune response. They play an important role in the body's anti-tumor, anti-infection, immune regulation, immune surveillance and maintenance of immune tolerance. This article reviews the generation and development of human gamma delta T cells, genetic characteristics, classification, recognition and role of antigens, and research progress in tumor immunotherapy.
引用
收藏
页数：14
相关论文
共 50 条
  • [41] Gene gun application in the generation of effector T cells for adoptive immunotherapy
    Tanigawa, K
    Yu, H
    Sun, R
    Nickoloff, BJ
    Chang, AE
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 48 (11) : 635 - 643
  • [42] Gene gun application in the generation of effector T cells for adoptive immunotherapy
    Keishi Tanigawa
    Hua Yu
    Rong Sun
    Brian J. Nickoloff
    Alfred E. Chang
    Cancer Immunology, Immunotherapy, 2000, 48 : 635 - 643
  • [43] Evolving Tumor Characteristics and Smart Nanodrugs for Tumor Immunotherapy
    Sun, Wenshe
    Xie, Shaowei
    Liu, Shi Feng
    Hu, Xiaokun
    Xing, Dongming
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 : 3919 - 3942
  • [44] New Era of Regulatory T Cells in Tumor Immunity: Insights in Cancer Immunotherapy
    Sheu, Bor-Ching
    Chang, Wen-Chun
    Huang, Su-Cheng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2010, 109 (01) : 1 - 3
  • [45] Stress response in tumor-infiltrating T cells is linked to immunotherapy resistance
    Nature Medicine, 2023, 29 : 1336 - 1337
  • [46] Adoptive immunotherapy with hyper-expanded tumor-reactive T cells
    Plautz, G
    Wang, LX
    Shu, SY
    JOURNAL OF IMMUNOTHERAPY, 2003, 26 (06): : S24 - S25
  • [47] Immunotherapy for Lymphoma Using T Cells Targeting Multiple Tumor Associated Antigens
    Leen, Ann
    Tzannou, Ifigeneia
    Bilgi, Munu
    Liu, Hao
    Vera, Juan F.
    Gerdemann, Ulrike
    Kamble, Rammurti T.
    Ramos, Carlos A.
    Grilley, Bambi
    Gee, Adrian P.
    Bollard, Catherine M.
    Brenner, Malcolm K.
    Heslop, Helen E.
    Rooney, Cliona M.
    Carrum, George
    BLOOD, 2015, 126 (23)
  • [48] Identification of human tumor antigens recognized by T-cells and their use for immunotherapy
    Kawakami, Y
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 77 (05) : 427 - 434
  • [49] Tumor-Associated Antigen Presentation by γδ T-Cells in Cancer Immunotherapy
    Kramer, Anne Marijn
    Yan, Mengyong
    Peggs, Karl S.
    Anderson, John
    Gustafsson, Kenth
    BLOOD, 2014, 124 (21)
  • [50] Time to Akt: Superior tumor-reactive T cells for adoptive immunotherapy
    van der Waart, Anniek B.
    Hobo, Willemijn
    Dolstra, Harry
    ONCOIMMUNOLOGY, 2015, 4 (05):
12345